Chris Jaynes Overview
- Company
- PERFUSIX Canada
- Primary Position
-
Co-Founder, Chie...
Chris Jaynes General Information
Biography
Mr. Chris Jaynes Co-Founded and served as Chief Executive Officer & Board Member at PERFUSIX Canada. Mr. Chris Jaynes began his career in the organ procurement field in 1992 with Donor Alliance. In 1996, Mr. Jaynes co-founded Statline, an organ transplant communication service company, which grew to a 70% market share in just three years and processed more than 3 million calls annually. Mr. Jaynes then launched a number of free-standing Medicare-Certified pulmonary rehabilitation clinics for patients awaiting lung transplant, turning into an innovative medical device and national rehabilitative service company which was acquired in 2005. Most recently, Mr. Jaynes was the Program Manager for XVIVO Perfusion. During this time he worked closely with the Toronto General Hospital surgeons Drs. Keshavjee, Cypel, and Waddell to develop and refine the ex-vivo lung perfusion technology. Mr. Jaynes was instrumental in the development processes from design and engineering through manufacturing and the regulatory approval.
Contact Information
Chris Jaynes FAQs
-
Who is Chris Jaynes?
Mr. Chris Jaynes Co-Founded and served as Chief Executive Officer & Board Member at PERFUSIX Canada.
-
How much does Chris Jaynes typically invest?
Chris Jaynes's median deal size is
. -
What is Chris Jaynes’s main position?
Chris Jaynes’s primary position is Co-Founder, Chief Executive Officer & Board Member.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »